Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Professor John O'Leary

Professor Consultant (Histopathology)
Professor Consultant (Molecular Medicine Ireland)
 (3531896) 3296
SIR PATRICK DUN LAB
      
Profile Photo

Professor John O'Leary

Professor Consultant (Histopathology)
SIR PATRICK DUN LAB

 olearyjj@tcd.ie

 3531896 3296

Professor Consultant (Molecular Medicine Ireland)

 (3531896) 3296


  Biomarkers of disease   Cervical Cancer   Development of array technologies   Molecular pathology   Prostate cancer
Details Date
Member, DMMC Cancer Principal Investigators, Trans-institutional grouping of Principal Investigators leading research on Cancer themes
Member, Core Technology PI's, DMMC Principal Investigators leading the development of core technology platforms.
Member, Centre for Molecular Research in Cancer (Proposed), This consortium combines researchers with common interest in understanding cell cycle signaling and regulation with specific focus on two key cancer-related processes (cell cycle control, apoptosis) and/or three specific malignancy types (oesophageal, prostate and haematological).
Invitee, Breast Cancer Consortium (Proposed), Investigators to be invited to participate in Breast Cancer workshop with a view to establishing formal consortium and informal individual collaborations.Last updated : 19 November 2004. Extract from DMMC Research Database
Bates M, Mohamed BM, Ward MP, Kelly TE, O'Connor R, Malone V, Brooks R, Brooks D, Selemidis S, Martin C, O'Toole S, O'Leary JJ., Circulating tumour cells: The Good, the Bad and the Ugly., Biochim Biophys Acta Rev Cancer, 1878, (2), 2023, p188863 , Journal Article, PUBLISHED  TARA - Full Text  DOI
Ffrench B, Kashdan E, Huang Y, Spillane CD, Cocchiglia S, Charmsaz S, Varešlija D, O'Brien C, Scholz D, Martin C, Gallagher M, Brooks DA, Brooks RD, Selemidis S, Gleeson N, AbuSaadeh F, O'Riain C, Kamran W, Flavin R, Young L, O'Toole SA, O'Leary JJ., CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity., Heliyon, 9, (1), 2023, pe13044 , Journal Article, PUBLISHED  DOI
Lazniewska J., Bader C., Hickey S.M., Selemidis S., O'Leary J., Simpson P.V., Stagni S., Plush S.E., Massi M., Brooks D., Rhenium ( I ) conjugates as tools for tracking cholesterol in cells, Metallomics, 14, (8), 2022, Journal Article, PUBLISHED  DOI
Martini C, Logan JM, Sorvina A, Gordon C, Beck AR, S-Y Ung B, Caruso MC, Moore C, Hocking A, Johnson IRD, Li KL, Karageorgos L, Hopkins AM, Esterman AJ, Huzzell C, Brooks RD, Lazniewska J, Hickey SM, Bader C, Parkinson-Lawrence E, Weigert R, Sorich MJ, Tewari P, Martin C, O'Toole S, Bates M, Ward M, Mohammed B, Keegan H, Watson W, Prendergast S, Heffernan S, NiMhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Brady N, Clarke A, Sokol F, Prabhakaran S, Stahl J, Klebe S, Samaratunga H, Delahunt B, Selemidis S, Moretti KL, Butler LM, O'Leary JJ, Brooks DA., Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer., Pathology, 2022, pS0031-3025(22)00226-4 , Journal Article, PUBLISHED  DOI
O'Donovan B., Mooney T., Rimmer B., Fitzpatrick P., Flannelly G., Doherty L., Russell N., Martin C.M., O'Leary J.J., Sharp L., O'Connor M., Corrigendum to "Trust and cancer screening: Effects of a screening controversy on women's perceptions of cervical cancer screening" [Prev. Med. Rep. 25 (2022) 101684] (Preventive Medicine Reports (2022) 25, (S2211335521003752), (10.1016/j.pmedr.2021.101684)), Preventive Medicine Reports, 27, 2022, Journal Article, PUBLISHED  DOI
O'Donovan B., Mooney T., Rimmer B., Fitzpatrick P., Flannelly G., Doherty L., Russell N., Martin C.M., O'Leary J.J., Sharp L., O'Connor M., Trust and cancer screening: Effects of a screening controversy on women's perceptions of cervical cancer screening, Preventive Medicine Reports, 25, 2022, Journal Article, PUBLISHED  DOI
O'Toole SA, Huang Y, Norris L, Power Foley M, Shireen R, McDonald S, Kamran W, Ibrahim N, Ward M, Thompson C, Murphy C, D'Arcy T, Farah N, Heron E, O'Leary JJ, Abu Saadeh F, Gleeson N., HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status., Gynecologic oncology, 2021, Journal Article, PUBLISHED  DOI
MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Gray SG, Reidy M, Nicholson S, Leonard N, Ryan R, Young V, O'Leary JJ, Cuffe S, Finn SP, O'Byrne KJ, Barr MP., MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer., Translational lung cancer research, 10, (4), 2021, p1773-1791 , Journal Article, PUBLISHED  DOI
O'Donovan B, Mooney T, Rimmer B, Fitzpatrick P, Flannelly G, Doherty L, Martin C, O'Leary J, O'Connor M, Sharp L., Advancing understanding of influences on cervical screening (non)-participation among younger and older women: A qualitative study using the theoretical domains framework and the COM-B model., Health expectations : an international journal of public participation in health care and health policy, 2021, Journal Article, PUBLISHED  DOI
Ward, Mark P., Saadeh, Feras Abu, O'Toole, Sharon A., O'Leary, John J., Gleeson, Noreen, Norris, Lucy A., Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway, Thrombosis Research, 200, 2021, p91 - 98, Journal Article, PUBLISHED  DOI
  

Page 1 of 21

  


Biomarkers of disease. Cervical Cancer. Development of array technologies. Molecular pathology. Prostate cancer.